Cargando…

PTEN Mutation Identified in Patient Diagnosed with Simultaneous Multiple Cancers

PTEN hamartoma tumor syndrome is a spectrum of disorders characterized by unique phenotypic features including multiple hamartomas caused by mutations of the tumor suppressor gene PTEN. Cowden syndrome and Bannayan–Riley–Ruvalcaba syndrome are representative diseases, and both have several common cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Won, Hye Sung, Chang, Eun Deok, Na, Sae Jung, Whang, In Yong, Lee, Dong Soo, You, Sun Hyong, Kim, Yong Seok, Kim, Jeong Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333971/
https://www.ncbi.nlm.nih.gov/pubmed/29510612
http://dx.doi.org/10.4143/crt.2017.579
Descripción
Sumario:PTEN hamartoma tumor syndrome is a spectrum of disorders characterized by unique phenotypic features including multiple hamartomas caused by mutations of the tumor suppressor gene PTEN. Cowden syndrome and Bannayan–Riley–Ruvalcaba syndrome are representative diseases, and both have several common clinical features and differences. Because PTEN mutations are associated with an increased risk of malignancy including breast, thyroid, endometrial, and renal cancers, cancer surveillance is an important element of disease management. We report a germline mutation of the PTEN (c.723dupT, exon 7) identified in a young woman with a simultaneous occurrence of breast cancer, dermatofibrosarcoma protuberans, and follicular neoplasm. This case suggests that it is critical for clinicians to recognize the phenotypic features associated with these syndromes to accurately diagnose them and provide preventive care.